Literature DB >> 2839545

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

A M Feldman1, A E Cates, W B Veazey, R E Hershberger, M R Bristow, K L Baughman, W A Baumgartner, C Van Dop.   

Abstract

Human heart failure is associated with a diminished contractile response to beta-adrenergic agonists. We hypothesized that alterations in the activity of a guanine nucleotide-binding regulatory protein (G protein) might be partially responsible for this abnormality. We therefore measured the activity of G proteins in failing human myocardium utilizing bacterial toxin-catalyzed ADP ribosylation. The activity of a 40,000-mol wt pertussis toxin substrate (alpha G40) was increased by 36% in failing human hearts when compared with nonfailing controls. In contrast, there was no change in the level of the stimulatory regulatory subunit (Gs). The increased activity in alpha G40 was associated with a 30% decrease in basal as well as 5'-guanylyl imidodiphosphate-stimulated adenylate cyclase activity. These data suggest that increased alpha G40 activity is a new marker for failing myocardium and may account at least in part for the diminished responsiveness to beta 1-adrenergic agonists in the failing human heart.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839545      PMCID: PMC303493          DOI: 10.1172/JCI113569

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Adenylate cyclase assay.

Authors:  Y Salomon
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

2.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

Authors:  D M Gill; R Meren
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase.

Authors:  G L Johnson; H R Kaslow; H R Bourne
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

4.  Selection of a variant lymphoma cell deficient in adenylate cyclase.

Authors:  H R Bourne; P Coffino; G M Tomkins
Journal:  Science       Date:  1975-02-28       Impact factor: 47.728

5.  Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants.

Authors:  P Coffino; H R Bourne; G M Tomkins
Journal:  J Cell Physiol       Date:  1975-06       Impact factor: 6.384

6.  Influence of cholera toxin on the regulation of adenylate cyclase by GTP.

Authors:  G L Johnson; H R Bourne
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

7.  Reconstitution of hormone-sensitive adenylate cyclase activity with resolved components of the enzyme.

Authors:  E M Ross; A C Howlett; K M Ferguson; A G Gilman
Journal:  J Biol Chem       Date:  1978-09-25       Impact factor: 5.157

8.  Fluoride stimulation of adenylate cyclase is dependent on the guanine nucleotide regulatory protein.

Authors:  R W Downs; A M Spiegel; M Singer; S Reen; G D Aurbach
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

9.  Histamine-mediated myocardial damage in rabbits.

Authors:  N E Kantrowitz; M R Bristow; W A Minobe; M E Billingham; D C Harrison
Journal:  J Mol Cell Cardiol       Date:  1982-09       Impact factor: 5.000

10.  Characteristics of the guanine nucleotide regulatory component of adenylate cyclase in human erythrocyte membranes.

Authors:  T B Nielsen; P M Lad; M S Preston; M Rodbell
Journal:  Biochim Biophys Acta       Date:  1980-04-17
View more
  107 in total

1.  Augmenting beta receptors in the heart: short-term gains offset by long-term pains?

Authors:  L E Limbird; D E Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Functional properties of the rat phosphatase 1alpha promoter.

Authors:  B Linck; P Boknik; J Knapp; K Kikuchi; H Lüss; F U Müller; K Nomoto; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

4.  Stimulatory guanine nucleotide-binding protein and adenylate cyclase activities in Bio 14.6 cardiomyopathic hamsters at the hypertrophic stage.

Authors:  T Ikegaya; A Kobayashi; R B Hong; H Masuda; M Kaneko; Y Noboru
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

Review 5.  β-Adrenergic receptor subtype signaling in heart: from bench to bedside.

Authors:  Anthony Yiu Ho Woo; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-01-30       Impact factor: 6.150

6.  Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.

Authors:  S A Akhter; C A Skaer; A P Kypson; P H McDonald; K C Peppel; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 7.  Alterations in adrenergic receptor signaling in heart failure.

Authors:  S Lamba; W T Abraham
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

Review 8.  Detrimental effects of beta-adrenergic stimulation on beta-adrenoceptors and microtubules in the heart.

Authors:  M Hori; Y Koretsune; H Sato; T Kagiya; A Kitabatake; T Kamada
Journal:  Heart Vessels Suppl       Date:  1991

9.  Inotropic response to DPI 201-106 in the failing human heart.

Authors:  M Böhm; F Diet; B Kemkes; M Wankerl; E Erdmann
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

10.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.